Legislation to Increase Uptake of HPV Vaccination and Adolescent Sexual Behaviors
- PMID: 30104422
- PMCID: PMC6317562
- DOI: 10.1542/peds.2018-0458
Legislation to Increase Uptake of HPV Vaccination and Adolescent Sexual Behaviors
Abstract
Background: Despite preventive health benefits of the human papillomavirus (HPV) vaccination, uptake in the United States remains low. Twenty-four states have enacted legislation regarding HPV vaccination and education. One reason these policies have been controversial is because of concerns that they encourage risky adolescent sexual behaviors. Our aim in this study is to determine if state HPV legislation is associated with changes in adolescent sexual behaviors.
Methods: This is a difference-in-difference study in which we use data on adolescent sexual behaviors from the school-based state Youth Risk Behavior Surveillance System from 2001 to 2015. Sexual behaviors included ever having sexual intercourse in the last 3 months and condom use during last sexual intercourse. We compared changes in sexual behaviors among high school students before and after HPV legislation to changes among high school students in states without legislation.
Results: A total of 715 338 participants reported ever having sexual intercourse in the last 3 months, and 217 077 sexually active participants reported recent condom use. We found no substantive or statistically significant associations between HPV legislation and adolescent sexual behaviors. Recent sexual intercourse decreased by 0.90 percentage points (P = .21), and recent condom use increased by 0.96 percentage points (P = .32) among adolescents in states that enacted legislation compared with states that did not. Results were robust to a number of sensitivity analyses.
Conclusions: Implementation of HPV legislation was not associated with changes in adolescent sexual behaviors in the United States. Concern that legislation will increase risky adolescent sexual behaviors should not be used when deciding to pass HPV legislation.
Copyright © 2018 by the American Academy of Pediatrics.
Conflict of interest statement
POTENTIAL CONFLICT OF INTEREST: The authors have indicated they have no potential conflicts of interest to disclose.
Figures
Similar articles
-
Sexual behavior and factors associated with young age at first intercourse and HPV vaccine uptake among young women in Germany: implications for HPV vaccination policies.BMC Public Health. 2014 Dec 5;14:1248. doi: 10.1186/1471-2458-14-1248. BMC Public Health. 2014. PMID: 25476713 Free PMC article.
-
Varying behavioral differences and correlates of HPV infection among young adolescents in Benue state, Nigeria.BMC Public Health. 2024 Jun 7;24(1):1548. doi: 10.1186/s12889-024-19068-7. BMC Public Health. 2024. PMID: 38849788 Free PMC article.
-
Human papillomavirus vaccine increases high-risk sexual behaviors: a myth or valid concern.J Sch Nurs. 2014 Dec;30(6):456-63. doi: 10.1177/1059840513520042. Epub 2014 Jan 11. J Sch Nurs. 2014. PMID: 24414172
-
Human Papillomavirus Vaccination and Sexual Disinhibition in Females: A Systematic Review.Am J Prev Med. 2016 Sep;51(3):373-83. doi: 10.1016/j.amepre.2016.03.015. Epub 2016 Apr 26. Am J Prev Med. 2016. PMID: 27130864 Review.
-
Tempest in a teapot: A systematic review of HPV vaccination and risk compensation research.Hum Vaccin Immunother. 2016 Jun 2;12(6):1435-50. doi: 10.1080/21645515.2016.1141158. Epub 2016 Feb 10. Hum Vaccin Immunother. 2016. PMID: 26864126 Free PMC article. Review.
Cited by
-
Human Papilloma Virus Vaccination and Oropharyngeal Cancer: Knowledge, Perception and Attitude among Italian Pediatric Dentists.Int J Environ Res Public Health. 2022 Jan 11;19(2):790. doi: 10.3390/ijerph19020790. Int J Environ Res Public Health. 2022. PMID: 35055612 Free PMC article.
-
Changes in Strength of Recommendation and Perceived Barriers to Human Papillomavirus Vaccination: Longitudinal Analysis of Primary Care Physicians, 2008-2018.J Pediatr. 2021 Jul;234:149-157.e3. doi: 10.1016/j.jpeds.2021.03.002. Epub 2021 Mar 6. J Pediatr. 2021. PMID: 33689710 Free PMC article.
-
Multi-component cancer prevention awareness program to improve adolescent HPV vaccine uptake.Hum Vaccin Immunother. 2021 Apr 3;17(4):1052-1058. doi: 10.1080/21645515.2020.1812316. Epub 2020 Oct 16. Hum Vaccin Immunother. 2021. PMID: 33064046 Free PMC article.
-
State statutes and regulations related to human papillomavirus vaccination.Hum Vaccin Immunother. 2019;15(7-8):1519-1526. doi: 10.1080/21645515.2019.1627817. Epub 2019 Jul 2. Hum Vaccin Immunother. 2019. PMID: 31241406 Free PMC article.
-
Human Papillomavirus Vaccines: Successes and Future Challenges.Drugs. 2018 Sep;78(14):1385-1396. doi: 10.1007/s40265-018-0975-6. Drugs. 2018. PMID: 30269207 Review.
References
-
- Satterwhite CL, Torrone E, Meites E, et al. . Sexually transmitted infections among US women and men: prevalence and incidence estimates, 2008. Sex Transm Dis. 2013;40(3):187–193 - PubMed
-
- Centers for Disease Control and Prevention Sexually Transmitted Disease Surveillance 2014. Atlanta, GA: US Department of Health and Human Services; 2015
-
- Food and Drug Administration June 8, 2006 Approval Letter - Human Papillomavirus Quadrivalent (Types 6, 11, 16, 18) Vaccine, Recombinant. Rockville, MD: Department of Health and Human Services; 2006. Available at: http://wayback.archive-it.org/7993/20170722145339/https://www.fda.gov/Bi.... Accessed July 7, 2018
-
- Food and Drug Administration October 16, 2009 Approval Letter - Cervarix. Rockville, MD: Department of Health and Human Services; 2009. Available at: http://wayback.archive-it.org/7993/20170723025640/https://www.fda.gov/Bi.... Accessed July 7, 2018
-
- Food and Drug Administration December 10, 2014 Approval Letter - GARDASIL 9. Rockville, MD: Department of Health and Human Services; 2014. Available at: https://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm.... Accessed July 7, 2018
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
